These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3057981)

  • 21. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
    Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
    Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Existence of alpha-1-fetoprotein in 8 patients with hereditary tyrosinemia. Preliminary report].
    Bélanger L; Bélanger M; Larochelle J
    Union Med Can; 1972 May; 101(5):877-8. PubMed ID: 4666892
    [No Abstract]   [Full Text] [Related]  

  • 24. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
    Pelet B; Antener I; Faggioni R; Spahr A; Gautier E
    Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary tyrosinemia].
    Rubecz I; Gombos A; Klujber L; Kádas I; Sipos J
    Orv Hetil; 1985 Dec; 126(51):3141-5. PubMed ID: 4080375
    [No Abstract]   [Full Text] [Related]  

  • 26. [A rare cause of neonatal hyperphenylalaninemia: tyrosinemia type I].
    Sarles J; Maurin N; Giraud F
    Pediatrie; 1992; 47(12):809-11. PubMed ID: 1338924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M; Tanguay RM
    Hum Mutat; 1997; 9(4):291-9. PubMed ID: 9101289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
    Kvittingen EA; Brodtkorb E
    Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestasis and hypermethioninemia during dietary management of hereditary tyrosinemia type 1.
    Ameen VZ; Powell GK; Rassin DK
    J Pediatr; 1986 Jun; 108(6):949-52. PubMed ID: 2872285
    [No Abstract]   [Full Text] [Related]  

  • 30. Hereditary tyrosinemia. General discussion: screening aspects.
    Can Med Assoc J; 1967 Oct; 97(18):1096-8. PubMed ID: 6050912
    [No Abstract]   [Full Text] [Related]  

  • 31. [Surgical excision of a hepatoma complicating chronic tyrosinemia (author's transl)].
    Costil J; Taïeb B; Buffe D; Garel L; Boccon-Gibod L; Gruner M; Brissaud HE
    Arch Fr Pediatr; 1980 Mar; 37(3):187-90. PubMed ID: 6258535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer.
    Phaneuf D; Hadchouel M; Tanguay RM; Bréchot C; Ferry N
    Biochem Biophys Res Commun; 1995 Mar; 208(3):957-63. PubMed ID: 7702626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients.
    Dubois J; Garel L; Patriquin H; Paradis K; Forget S; Filiatrault D; Grignon A; Russo P; St-Vil D
    Pediatr Radiol; 1996 Dec; 26(12):845-51. PubMed ID: 8929295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary tyrosinemia type III].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):137-40. PubMed ID: 9590008
    [No Abstract]   [Full Text] [Related]  

  • 35. [Disorders in the tyrosine metabolism. II. Tyrosinemia - a congenital metabolic disorder].
    Vulović D; Hajduković R; Sindjić M; FilipovićD ; Dozić S
    Srp Arh Celok Lek; 1974 Jan; 102(1):9-20. PubMed ID: 4368107
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hereditary tyrosinemia and vitamin-dependent rickets in Saguenay. A genetic and demographic approach].
    Bouchard G; Laberge C; Scriver CR
    Union Med Can; 1985 Aug; 114(8):633-6. PubMed ID: 4060342
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver disease in hereditary tyrosinemia.
    Gagné R
    N Engl J Med; 1983 Oct; 309(17):1063. PubMed ID: 6621647
    [No Abstract]   [Full Text] [Related]  

  • 38. The genetic tyrosinemias.
    Scott CR
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):121-6. PubMed ID: 16602095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the renal tubular damage in hereditary tyrosinemia and on the formation of succinylacetoacetate and succinylacetone.
    Fällström SP; Lindblad B; Steen G
    Acta Paediatr Scand; 1981; 70(3):315-20. PubMed ID: 7246125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
    Berger R; van Faassen H; Smith GP
    Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.